On January 2, 2025, John P. Bilbrey, a director of Colgate-Palmolive, acquired 228 shares of Common Stock at $93.18 per share through a grant or award. The transaction was executed under the transaction code 'A', indicating an acquisition.Following this transaction, Bilbrey's direct ownership increased to 33,273 shares. Additionally, he indirectly owns 4,719 shares through a trust. The total value of the acquired shares amounts to approximately $21,245.This stock acquisition aligns with typical executive compensation practices and may indicate the company's efforts to align the director's interests with those of shareholders. The transaction has been completed, with all relevant details reported as required by SEC regulations.

On January 2, 2025, John P. Bilbrey, a director of Colgate-Palmolive, acquired 228 shares of Common Stock at $93.18 per share through a grant or award. The transaction was executed under the transaction code 'A', indicating an acquisition.Following this transaction, Bilbrey's direct ownership increased to 33,273 shares. Additionally, he indirectly owns 4,719 shares through a trust. The total value of the acquired shares amounts to approximately $21,245.This stock acquisition aligns with typical executive compensation practices and may indicate the company's efforts to align the director's interests with those of shareholders. The transaction has been completed, with all relevant details reported as required by SEC regulations.